2bPrecise News
13 articles2bPrecise Named "Best Overall Genomics Company" in 2022 MedTech Breakthrough Awards Program
2bPrecise Joins the Epic App Orchard to Bring Its Precision Medicine Insights to the Point of Care
AccessDX Holdings Acquires 2bPrecise
Q-State Biosciences and 2bPrecise Announce Partnership
growth-positive
Summit Healthcare selects 2bPrecise for Pharmacogenomics
Allscripts Healthcare Solutions, Inc. announced that Summit Healthcare will implement the 2bPrecise precision health platform to enhance clinical outcomes and the patient experience. Summit Healthcare, located in Show Low, AZ, will use the platform to prescribe patient medications based on genetic information. The platform consumes data from any lab source or knowledge base and delivers it in an actionable format to the clinical workflow. Summit Healthcare expects the platform to have a significant impact on patient care decisions and help manage costs. The implementation coincides with Summits conversion to Allscripts Sunrise EHR.
PartnersCustomers
Genesys PHO Selects 2bPrecise to Optimize Patient Well-being
2bPrecise Honored as One of Israel's Top Startups
2bPrecise and PierianDx Collaborate to Deliver a Comprehensive Precision Medicine Solution
growth-positive
University Hospitals selects 2bPrecise to deliver genomic insights at point of care
University Hospitals has selected the 2bPrecise platform to integrate genomic data into the clinical workflow, impacting patient care. The platform is cloud-based and EHR-agnostic, allowing clinicians to access genomic insights without leaving their preferred workflows. The collaboration aims to make healthcare more personalized for all patients. The 2bPrecise approach to precision medicine is flexible and scalable, enabling organizations to expand to other areas. University Hospitals will use the gene data to align tests and treatments for patients with specific conditions. The partnership with Allscripts will help University Hospitals achieve immediate results and scale over time.
Customers
2bPrecise and The Innovation Institute to Deliver Robust Pharmacogenomics Platform, GeneFolio, to the Point of Care
growth-positive
2bPrecise, Mayo Clinic Collaborate On Genomics Care Protocols
Mayo Clinic has partnered with precision medicine platform vendor 2bPrecise to develop and test care protocols for genomics. Mayo has also licensed 2bPrecise technology for use by its own clinicians. The collaboration will initially focus on familial hypercholesterolemia, a specific cardiovascular condition. 2bPrecise is a cloud-based technology that combines genomic, clinical, and lifestyle information to provide clinicians with access to structured data for analysis and pattern detection. The platform simplifies the process of finding, selecting, ordering, and receiving the results of genomics tests.
PartnersCustomers
2bPrecise Now Brings Actionable Pharmacogenomics Data to the Point of Care
growth-positive
2bPrecise, an Allscripts company, launches a Genomics and Precision Medicine Initiative at National Institutes of Health
2bPrecise LLC, a subsidiary of Allscripts Healthcare Inc., has launched a strategic early adopter program at the National Institutes of Health (NIH) to deploy a cloud-based genomics and precision medicine solution. The program aims to simplify and optimize the process of finding, selecting, ordering, and receiving genomic tests. The solution will be integrated into Allscripts Sunrise electronic health record (EHR) and will be used by leading physicians in genomic medicine at NIH. The solution will also enable statistical analysis and pattern detection by combining genomic data with clinical and environmental information. The program will eventually be available to other healthcare providers and organizations. 2bPrecise LLC is focused on enabling clinical utilization of precision medicine data.
Partners
